BioSpace News Archive

Cybin Inc. announced that it has successfully achieved its research and development milestones that helped to build and progress its innovative pipeline of investigational psychedelic therapeutics ahead of projected timelines.

Zentek Ltd. announces that Greg Fenton, CEO, will hold investor meetings and present at this year’s Sidoti Small-Cap Virtual Investor Conference, which will be held September 21-22, 2022.

Aytu BioPharma, Inc. will report financial results for its fourth quarter and fiscal year ended June 30, 2022, after the market close on Tuesday, September 27, 2022.

Stryker announced today that its OptaBlate bone tumor ablation system (OptaBlate) received 510(k) clearance from the U.S. Food and Drug Administration.

Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Versions of TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, with 180 days Competitive Generic Therapy (CGT) exclusivity.

DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced the appointment of Stephen Nuckols as Chief Commercial Officer.

Invitae (NYSE: NVTA) and Praxis Precision Medicines , Inc. (NASDAQ: PRAX), today announced that real-world clinical insights from Invitae’s Ciitizen platform were utilized as natural history data to support the submission of Praxis’ Investigational New Drug (IND) application for PRAX-222 for the treatment of pediatric patients with early-onset SCN2A developmental and epileptic encephalopathy (DEE).

Schrödinger today announced that the company will host Platform Day in New York City on Thursday, October 6, 2022, beginning at 10:00 AM ET.

MathWorks today unveiled Release 2022b (R2022b) of the MATLAB® and Simulink® product families.

Today, Glencoe Software is pleased to announce the release of NGFF-Converter, an easy-to-use open source tool for generating cloud-friendly bioimaging data.